Over past decades, nuclear medicine pro- cedures have acquired a relevant role in the detection of neuroendocrine tumours (NET), and the recent introduction of speci*c PET tracers for NET studies has further increased nuclear physicians’ diagnostic and therapeutic (peptide receptor radionuclide therapy, PRRT) interest in this subset of tumours. Knowledge of the biological features of NET is of crucial importance in understanding the mechanism of action and the potential clinical relevance of the radiotracers currently used in NET imaging, since nuclear medicine compounds have been designed taking into account the speci*c characteristics of NET cells.
Clinical applications of PET/CT in oncology:Neuroendocrine tumour / V. Ambrosini; S. Fanti. - STAMPA. - (2011), pp. 102-107.
Clinical applications of PET/CT in oncology:Neuroendocrine tumour
AMBROSINI, VALENTINA;FANTI, STEFANO
2011
Abstract
Over past decades, nuclear medicine pro- cedures have acquired a relevant role in the detection of neuroendocrine tumours (NET), and the recent introduction of speci*c PET tracers for NET studies has further increased nuclear physicians’ diagnostic and therapeutic (peptide receptor radionuclide therapy, PRRT) interest in this subset of tumours. Knowledge of the biological features of NET is of crucial importance in understanding the mechanism of action and the potential clinical relevance of the radiotracers currently used in NET imaging, since nuclear medicine compounds have been designed taking into account the speci*c characteristics of NET cells.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
